Guimin Xia

586 total citations
24 papers, 470 citations indexed

About

Guimin Xia is a scholar working on Molecular Biology, Biomaterials and Oncology. According to data from OpenAlex, Guimin Xia has authored 24 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 10 papers in Biomaterials and 7 papers in Oncology. Recurrent topics in Guimin Xia's work include Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Guimin Xia is often cited by papers focused on Nanoparticle-Based Drug Delivery (10 papers), RNA Interference and Gene Delivery (6 papers) and Nanoplatforms for cancer theranostics (4 papers). Guimin Xia collaborates with scholars based in China, India and United Kingdom. Guimin Xia's co-authors include Xiaowei Wang, Mingliang Liu, Wuli Zhao, Zhonggao Gao, Rong‐Guang Shao, Mingji Jin, Mengyan Wang, Yun Chai, Cong-Hui Zhang and Tianshu Zhang and has published in prestigious journals such as ACS Nano, PLoS ONE and Journal of Controlled Release.

In The Last Decade

Guimin Xia

24 papers receiving 461 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guimin Xia China 12 231 169 124 93 66 24 470
Dasharath Chaudhari India 16 230 1.0× 230 1.4× 143 1.2× 68 0.7× 95 1.4× 28 577
Joachim Caron France 15 266 1.2× 167 1.0× 95 0.8× 181 1.9× 67 1.0× 18 572
Sandeep Urandur India 13 197 0.9× 156 0.9× 151 1.2× 47 0.5× 71 1.1× 16 438
Tushar Date India 14 201 0.9× 190 1.1× 103 0.8× 41 0.4× 64 1.0× 22 493
Amit Singh United States 7 308 1.3× 216 1.3× 150 1.2× 42 0.5× 80 1.2× 7 595
Jérôme Bejaud France 17 352 1.5× 269 1.6× 157 1.3× 88 0.9× 75 1.1× 28 698
Chengan Du United States 6 193 0.8× 134 0.8× 75 0.6× 39 0.4× 71 1.1× 12 375
Kuo‐Hsiang Chuang Taiwan 14 321 1.4× 136 0.8× 126 1.0× 51 0.5× 79 1.2× 32 605
Seulki Lee South Korea 9 260 1.1× 193 1.1× 185 1.5× 39 0.4× 78 1.2× 13 556
Galya Warren United States 8 168 0.7× 168 1.0× 143 1.2× 33 0.4× 103 1.6× 10 445

Countries citing papers authored by Guimin Xia

Since Specialization
Citations

This map shows the geographic impact of Guimin Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guimin Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guimin Xia more than expected).

Fields of papers citing papers by Guimin Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guimin Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guimin Xia. The network helps show where Guimin Xia may publish in the future.

Co-authorship network of co-authors of Guimin Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Guimin Xia. A scholar is included among the top collaborators of Guimin Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guimin Xia. Guimin Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wang, Dan, Xiaobo Wang, Yan Li, et al.. (2024). Improved Antitumor Efficiency of N4-Tetradecyloxycarbonyl Gemcitabine-Loaded Liposomes for Pancreatic Cancer Chemotherapy. International Journal of Nanomedicine. Volume 19. 13391–13410. 1 indexed citations
3.
Wang, Xiaowei, Hongwei Lü, Fang Luo, et al.. (2023). Lipid-like gemcitabine diester-loaded liposomes for improved chemotherapy of pancreatic cancer. Journal of Controlled Release. 365. 112–131. 10 indexed citations
4.
5.
Wang, Apeng, Yun Chai, Guimin Xia, et al.. (2021). Design, synthesis and biological evaluation of nitrofuran-1,3,4-oxadiazole hybrids as new antitubercular agents. Bioorganic & Medicinal Chemistry. 53. 116529–116529. 10 indexed citations
6.
Wang, Apeng, Yun Chai, Guimin Xia, et al.. (2021). Design, synthesis and biological activity of N-(amino)piperazine-containing benzothiazinones against Mycobacterium tuberculosis. European Journal of Medicinal Chemistry. 218. 113398–113398. 21 indexed citations
7.
Wang, Dan, Xiaowei Wang, Dongfang Lin, et al.. (2021). Promoted antitumor therapy on pancreatic cancer by a novel recombinant human albumin-bound miriplatin nanoparticle. European Journal of Pharmaceutical Sciences. 167. 106000–106000. 5 indexed citations
8.
Wang, Dan, Xuelei Wang, Li Wang, et al.. (2021). Antisense microRNA185 loaded liposome for efficient inhibition of the hepatic endogenous microRNA185 level. European Journal of Pharmaceutical Sciences. 161. 105803–105803. 6 indexed citations
9.
Wang, Xiaowei, Yuhan Qiu, Mengyan Wang, et al.. (2020). <p>Endocytosis and Organelle Targeting of Nanomedicines in Cancer Therapy</p>. International Journal of Nanomedicine. Volume 15. 9447–9467. 92 indexed citations
10.
Wang, Apeng, Yu Lu, Kai Lv, et al.. (2020). Design, synthesis and antimycobacterial activity of new benzothiazinones inspired by rifampicin/rifapentine. Bioorganic Chemistry. 102. 104135–104135. 10 indexed citations
11.
Wang, Xiaowei, Dan Wang, Xuelei Wang, et al.. (2020). Evaluation of antitumor efficacy of folate-poly(2-ethyl-2-oxazoline)-distearoyl phosphatidyl ethanolamine based liposome. Pharmaceutical Development and Technology. 26(1). 110–118. 5 indexed citations
12.
Xu, Jian, Yue Du, Wenjuan Liu, et al.. (2017). Intensive fibrosarcoma-binding capability of the reconstituted analog and its antitumor activity. Drug Delivery. 25(1). 102–111. 5 indexed citations
13.
Wang, Chunlan, Guimin Xia, Xiujun Liu, et al.. (2016). Synthesis and antitumor activity of ATB-429 derivatives containing a nitric oxide-releasing moiety. Bioorganic & Medicinal Chemistry Letters. 26(9). 2355–2359. 11 indexed citations
14.
Jia, Xuedong, Shuo Wang, Minghua Wang, et al.. (2016). Synthesis and in vitro antitumor activity of novel naphthyridinone derivatives. Chinese Chemical Letters. 28(2). 235–239. 45 indexed citations
15.
Liu, Shan, Wei Huang, Mingji Jin, et al.. (2015). Inhibition of murine breast cancer growth and metastasis by survivin-targeted siRNA using disulfide cross-linked linear PEI. European Journal of Pharmaceutical Sciences. 82. 171–182. 42 indexed citations
16.
Liu, Shan, Yunfei Li, Xiaowei Wang, et al.. (2015). Preparation, Characterization, and Antitumor Activities of Miriplatin-Loaded Liposomes. Journal of Pharmaceutical Sciences. 105(1). 78–87. 13 indexed citations
17.
Li, Yunfei, Mingji Jin, Shuai Shao, et al.. (2014). Small-sized polymeric micelles incorporating docetaxel suppress distant metastases in the clinically-relevant 4T1 mouse breast cancer model. BMC Cancer. 14(1). 329–329. 38 indexed citations
18.
Zhao, Chen, Qiang Feng, Wei Yuan, et al.. (2013). Local Targeted Therapy of Liver Metastasis from Colon Cancer by Galactosylated Liposome Encapsulated with Doxorubicin. PLoS ONE. 8(9). e73860–e73860. 29 indexed citations
19.
Wang, Xueqing, Zhen Chen, Tao Zhang, et al.. (2004). Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration. Journal of Controlled Release. 97(3). 421–429. 48 indexed citations
20.
Chen, Zhe, et al.. (2004). [Influence of suspending agents on relative bioavailability of cyclosporine A-loaded HPMCP nanoparticles for oral administration to rats].. PubMed. 36(3). 305–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026